涛生医药 (839411.OC)

+ 收藏

财务摘要(报告期)(涛生医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
每股指标:
 每股收益 - 基本(元) -0.17-0.080.02-0.31-0.14
 每股收益 - 稀释(元) -0.17-0.130.02-0.31-0.14
 每股收益 - 期末股本摊薄(元) -0.17-0.080.02-0.31-0.14
 每股净资产BPS(元) 0.470.640.750.730.87
 每股经营活动产生的现金流量净额(元) 0.140.080.340.260.08
 每股营业收入(元) 0.711.190.361.340.63
关键比率:
 净资产收益率 - 摊薄(%) -35.21-13.182.72-42.65-15.56
 净资产收益率 - 加权(%) -16.06-12.242.76-36.41-14.44
 净资产收益率 - 平均(%) -29.94-12.302.76-35.98-14.44
 净资产收益率 - 扣除(%) -35.83-27.372.60-38.23-13.65
 总资产净利率 - 平均(%) -7.37-3.470.85-13.58-6.27
 总资产报酬率ROA(%) -6.59-1.271.54-12.46-5.60
 投入资本回报率ROIC(%) -9.26-2.892.24-17.00-7.43
 销售毛利率(%) -6.2815.2120.1613.7418.76
 销售净利率(%) -28.35-7.445.62-24.93-23.59
 资产负债率(%) 65.7957.7157.2459.5255.96
 资产周转率(倍) 0.260.470.150.540.27
 销售商品提供劳务收到的现金/营业收入(%) 162.03126.23174.04134.71143.03
 营业利润同比增长率(%) -1,253.4467.77114.7948.39-51.88
 营业收入同比增长率(%) 96.49-11.23-42.35-49.34-41.54
 利润总额同比增长率(%) -1,151.9679.93112.8741.65-85.37
 归属母公司股东的净利润同比增长率(%) -914.7872.96115.1641.74-90.71
 扣非后归属母公司股东的净利润同比增长率(%) -966.6237.34116.5345.77-66.67
 总资产同比增长率(%) 16.6712.327.74-4.62-27.68
 总负债同比增长率(%) 34.108.9010.191.52-13.27
 净资产同比增长率(%) -37.03-12.48-13.32-27.04-40.87
利润表摘要:
 营业总收入(元) 47,088,576.1179,108,556.4623,964,555.8689,119,275.2441,571,371.65
 营业总成本(元) 60,766,350.8392,120,005.0832,415,626.76106,196,551.7149,259,683.11
 营业收入(元) 47,088,576.1179,108,556.4623,964,555.8689,119,275.2441,571,371.65
 营业利润(元) -13,899,590.38-6,327,601.381,205,055.69-19,630,111.05-8,150,340.62
 利润总额(元) -13,395,245.22-4,556,192.591,273,363.49-22,698,837.34-9,896,488.75
 净利润(元) -13,348,710.48-5,882,065.161,347,392.30-22,215,173.68-9,808,173.08
 归属母公司股东的净利润(元) -11,114,985.01-5,624,329.641,364,174.33-20,796,533.72-9,000,337.93
 非经常性损益(元) 193,658.866,057,182.4959,266.99-2,152,447.87-1,104,048.57
 归属母公司股东的净利润扣除非经常性损益(元) -11,308,643.87-11,681,512.131,304,907.34-18,644,085.85-7,896,289.36
资产负债表摘要:
 流动资产(元) 66,421,762.8077,019,010.6776,698,969.5792,231,112.3693,170,374.84
 固定资产(元) 18,872,587.0919,405,887.0219,043,991.4120,334,329.2821,379,566.39
 资产总计(元) 182,743,140.89179,419,108.87156,638,122.31159,740,604.46145,379,195.94
 流动负债(元) 93,232,507.1089,920,269.4080,032,424.7790,183,605.9866,409,733.34
 非流动负债(元) 26,986,922.0213,626,417.229,619,950.964,898,868.0414,949,373.21
 负债合计(元) 120,219,429.12103,546,686.6289,652,375.7395,082,474.0281,359,106.55
 股东权益(元) 62,523,711.7775,872,422.2566,985,746.5864,658,130.4464,020,089.39
 归属母公司股东的权益(元) 31,564,459.3542,679,444.3650,127,006.6548,762,832.3257,831,400.00
 资本公积(元) 29,986,131.0629,986,131.0630,445,189.3830,445,189.3827,717,561.27
 盈余公积(元) 1,050,846.721,050,846.721,050,846.721,050,846.721,050,846.72
 未分配利润(元) -65,975,818.43-54,860,833.42-47,872,329.45-49,236,503.78-37,440,307.99
现金流量表摘要:
 销售商品提供劳务收到的现金(元) 76,298,299.7299,861,706.3041,707,068.18120,051,035.9159,457,970.28
 经营活动产生的现金净流量(元) 9,607,048.784,992,519.6322,772,281.0417,618,614.125,379,211.77
 购建固定无形长期资产支付的现金(元) 17,840,500.2046,220,198.4626,342,896.0223,266,695.593,432,263.06
 投资活动产生的现金净流量(元) -17,792,100.20-47,038,266.98-27,360,964.54-21,796,695.59-2,762,263.06
 吸收投资收到的现金(元) -16,116,133.14-13,045,041.65-
 取得借款收到的现金(元) 21,700,000.0062,738,958.8929,488,958.8928,558,426.7110,568,537.99
 筹资活动产生的现金净流量(元) 8,341,591.4136,768,233.737,969,090.597,080,563.15-4,556,145.96
 现金及现金等价物净增加(元) 156,539.99-5,277,513.623,380,407.092,902,481.68-1,939,197.25
 期末现金及现金等价物余额(元) 6,332,976.506,176,436.5114,834,357.2211,453,950.136,612,271.20
 折旧与摊销(元) -3,776,416.842,229,604.704,864,808.422,828,759.69
公告日期 2024-08-292024-04-242023-08-282023-04-142022-08-24
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院